NASDAQ
Kairos Pharma, Ltd. (KAPA) has a current ratio of 27.07x as of Monday, May 25, 2026. This represents a 2279.91% increase compared to its 12-month average of 1.14x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.